SPLIT SEPTUM INJECTION SITES
K-Number: K041042 · 2004-07-16
Advertisement
Device Summary
Frequently Asked Questions
What is the SPLIT SEPTUM INJECTION SITES?
SPLIT SEPTUM INJECTION SITES is a medical device that received FDA 510(k) clearance on 2004-07-16. The listed applicant is Fresenius Medical Care North America. The 510(k) number is K041042.
When did SPLIT SEPTUM INJECTION SITES receive FDA 510(k) clearance?
SPLIT SEPTUM INJECTION SITES received FDA 510(k) clearance on 2004-07-16, under 510(k) number K041042.
Who is the listed applicant for SPLIT SEPTUM INJECTION SITES?
The FDA 510(k) record lists Fresenius Medical Care North America as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for SPLIT SEPTUM INJECTION SITES?
The FDA product code for SPLIT SEPTUM INJECTION SITES is FPA.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Fresenius Medical Care North America as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: FPA)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement